Di Micco, S.; Musella, S.; Sala, M.; Scala, M.C.; Andrei, G.; Snoeck, R.; Bifulco, G.; Campiglia, P.; Fasano, A.
Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. Int. J. Mol. Sci. 2021, 22, 9427.
https://doi.org/10.3390/ijms22179427
AMA Style
Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.
Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. International Journal of Molecular Sciences. 2021; 22(17):9427.
https://doi.org/10.3390/ijms22179427
Chicago/Turabian Style
Di Micco, Simone, Simona Musella, Marina Sala, Maria C. Scala, Graciela Andrei, Robert Snoeck, Giuseppe Bifulco, Pietro Campiglia, and Alessio Fasano.
2021. "Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation" International Journal of Molecular Sciences 22, no. 17: 9427.
https://doi.org/10.3390/ijms22179427
APA Style
Di Micco, S., Musella, S., Sala, M., Scala, M. C., Andrei, G., Snoeck, R., Bifulco, G., Campiglia, P., & Fasano, A.
(2021). Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. International Journal of Molecular Sciences, 22(17), 9427.
https://doi.org/10.3390/ijms22179427